Skip to main content

Table 2 Association of SNPs in the LTA and TNFA genes with Chronic Obstructive Pulmonary Disease (COPD)

From: TNFA-863 polymorphism is associated with a reduced risk of Chronic Obstructive Pulmonary Disease: A replication study

   

COPD cases vs. healthy control

Gene position

SNP ID

Seattle SNP database

COPD cases MAF %

Healthy controls MAF %

ORadj (95% CI) a

P-value*

LTA

      

+49(C/A)

rs2239704

Lt_2202

0.42

0.39

1.05 (0.79-1.4)

0.73

+252(A/G)

rs909253

Lt_2374

0.30

0.30

1.08 (0.79-1.46)

0.63

+495(T/C)

rs2229094

Lt_2619

0.31

0.33

0.83 (0.62-1.11)

0.2

+720(C/A)

rs1041981

Lt_2847

0.29

0.30

1.05 (0.77-1.42)

0.78

TNFA

      

-863(C/A)

rs1800630

Lt_4539

0.16

0.22

0.58 (0.41-0.83)

0.002

     

0.50 (0.33-0.77)

0.001**

-857(C/T)

rs1799724

Lt_4545

0.09

0.09

1.41 (0.88-2.27)

0.16

-376(G/A)

rs1800750

TNF_214

0.04

0.03

1.30 (0.64-2.66)

0.47

-308(G/A)

rs1800629

TNF_282

0.15

0.15

0.97 (0.66-1.42)

0.87

-238(G/A)

rs361525

TNF_352

0.06

0.06

1.25 (0.72-2.19)

0.43

+489(G/A)

rs180610

TNF_1078

0.09

0.09

1.42 (0.88-2.22)

0.15

  1. Data are presented as MAF: minor allele frequency (%). ORadj: odds ratio; CI: confidence interval. *p values < 0.05. Age and gender were included in a multivariate logistic regression analyses as potential confounding factors in an additive model. **p value from a dominant genetic model.